These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26512599)

  • 1. Characterization of Benign Myocarditis Using Quantitative Delayed-Enhancement Imaging Based on Molli T1 Mapping.
    Toussaint M; Gilles RJ; Azzabou N; Marty B; Vignaud A; Greiser A; Carlier PG
    Medicine (Baltimore); 2015 Oct; 94(43):e1868. PubMed ID: 26512599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.
    Radunski UK; Lund GK; Säring D; Bohnen S; Stehning C; Schnackenburg B; Avanesov M; Tahir E; Adam G; Blankenberg S; Muellerleile K
    Clin Res Cardiol; 2017 Jan; 106(1):10-17. PubMed ID: 27388331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.
    de Meester de Ravenstein C; Bouzin C; Lazam S; Boulif J; Amzulescu M; Melchior J; Pasquet A; Vancraeynest D; Pouleur AC; Vanoverschelde JL; Gerber BL
    J Cardiovasc Magn Reson; 2015 Jun; 17(1):48. PubMed ID: 26062931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study.
    Treiber J; Novak D; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Weferling M; von Jeinsen B; Hain A; Rieth AJ; Siemons T; Keller T; Hamm CW; Rolf A
    J Cardiovasc Magn Reson; 2023 Feb; 25(1):8. PubMed ID: 36755275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.
    Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
    J Cardiovasc Magn Reson; 2014 May; 16(1):36. PubMed ID: 24886708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of native and contrast-enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques.
    Nadjiri J; Nieberler H; Hendrich E; Greiser A; Will A; Martinoff S; Hadamitzky M
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):539-547. PubMed ID: 27878700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial Partition Coefficient of Gadolinium: A Pilot Study in Patients With Acute Myocarditis, Chronic Myocardial Infarction, and in Healthy Volunteers.
    Teixeira T; Hafyane T; Jerosch-Herold M; Marcotte F; Mongeon FP
    Can J Cardiol; 2019 Jan; 35(1):51-60. PubMed ID: 30595183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative inversion time prescription for myocardial late gadolinium enhancement using T1-mapping-based synthetic inversion recovery imaging: reducing subjectivity in the estimation of inversion time.
    Gassenmaier S; van der Geest RJ; Schoepf UJ; Suranyi P; Rehwald WG; De Cecco CN; Mastrodicasa D; Albrecht MH; De Santis D; Lesslie VW; Ruzsics B; Varga-Szemes A
    Int J Cardiovasc Imaging; 2018 Jun; 34(6):921-929. PubMed ID: 29305739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study.
    Bandettini WP; Kellman P; Mancini C; Booker OJ; Vasu S; Leung SW; Wilson JR; Shanbhag SM; Chen MY; Arai AE
    J Cardiovasc Magn Reson; 2012 Nov; 14(1):83. PubMed ID: 23199362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative T1 Mapping for Detecting Microvascular Obstruction in Reperfused Acute Myocardial Infarction: Comparison with Late Gadolinium Enhancement Imaging.
    Shin JM; Choi EY; Park CH; Han K; Kim TH
    Korean J Radiol; 2020 Aug; 21(8):978-986. PubMed ID: 32677382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.
    Ugander M; Oki AJ; Hsu LY; Kellman P; Greiser A; Aletras AH; Sibley CT; Chen MY; Bandettini WP; Arai AE
    Eur Heart J; 2012 May; 33(10):1268-78. PubMed ID: 22279111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.
    Kellman P; Wilson JR; Xue H; Bandettini WP; Shanbhag SM; Druey KM; Ugander M; Arai AE
    J Cardiovasc Magn Reson; 2012 Sep; 14(1):64. PubMed ID: 22967246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging.
    Radunski UK; Lund GK; Stehning C; Schnackenburg B; Bohnen S; Adam G; Blankenberg S; Muellerleile K
    JACC Cardiovasc Imaging; 2014 Jul; 7(7):667-75. PubMed ID: 24954462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native T1 mapping to detect extent of acute and chronic myocardial infarction: comparison with late gadolinium enhancement technique.
    Dastidar AG; Harries I; Pontecorboli G; Bruno VD; De Garate E; Moret C; Baritussio A; Johnson TW; McAlindon E; Bucciarelli-Ducci C
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):517-527. PubMed ID: 30357547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.
    Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
    J Cardiovasc Magn Reson; 2012 May; 14(1):27. PubMed ID: 22548832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free-breathing combined three-dimensional phase sensitive late gadolinium enhancement and T1 mapping for myocardial tissue characterization.
    Weingärtner S; Akçakaya M; Roujol S; Basha T; Tschabrunn C; Berg S; Anter E; Nezafat R
    Magn Reson Med; 2015 Oct; 74(4):1032-41. PubMed ID: 25324205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of myocarditis using T
    Lundin M; Sörensson P; Vishnevskaya L; Maret E; Kellman P; Sigfridsson A; Ugander M
    Clin Physiol Funct Imaging; 2019 Nov; 39(6):384-392. PubMed ID: 31132211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.